Climb Bio CLYM
Climb Bio: Ownership stake disclosure (amended)
Schedule 13D/A on Climb Bio (CLYM), filed with the SEC on Nov 9, 2026, 5:32 pm ET. Source: the filing on SEC EDGAR.
Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)
- Form
- Schedule 13D/A
- Filed
- Importance
- Notable
- Accession
- 0001346824-26-000257
- RA Capital Management, L.P. and affiliates hold 3,893,741 shares directly
- Pre-Funded Warrants could add 22,546,000 shares if exercised
- RA Capital Nexus Fund III holds 3,679,649 shares directly
Written from the Schedule 13D/A on EDGAR. AI can make mistakes. Check the filing.
